Pain Syndrome Removing at Patients with Temporomandibular Joint Disorders  and Urinary System

Natali Timoshchenko

Authors

Natali Timoshchenko

Keywords:

meloxicam, temporomandibular joint, osteoarthritis, urinary diseases

Abstract

Abstract not found

Downloads

How to Cite

Pain Syndrome Removing at Patients with Temporomandibular Joint Disorders and Urinary System. (2017). Global Journal of Medical Research, 17(K6), 17-22. https://medicalresearchjournal.org/index.php/GJMR/article/view/1425

Download Citation

References

V Badokin (2009) Multifactority of mechanisms of action of non-steroidal anti-inflammatory drugs at osteoarthrosis // Modern Rheumatology. 81-87.

M Batyushin, A Litvinov, V Terentyev, L Rudenko, D Tsvetkov, A Galushkin, M Gasanov, V Poganeva (2012) Risk stratification of development and CKD progression and analysis of deletion polymorphism of angiotensin converting enzyme. 24, e71.

Carol Burckhardt, Kim Jones (2003) Adult measures of pain: The McGill Pain Questionnaire (MPQ), Rheumatoid Arthritis Pain Scale (RAPS), Short-Form McGill Pain Questionnaire (SF-MPQ), Verbal Descriptive Scale (VDS), Visual Analog Scale (VAS), and West Haven-Yale Multidisciplinary Pain Inventory (WHYMPI). 49(S5), S96-S104.

P Dey, S Maiti (2010) Orodispersible tablets: A new trend in drug delivery. 1(1), 2-5.

Changhai Ding (2002) Do NSAIDs Affect the Progression of Osteoarthritis?. 26(3), 139-142.

F Gaston-Johansson (1996) Measurement of pain: The psychometric properties of the Pain-O-Meter, a simple, inexpensive pain assessment tool that could change health care practices. 12(3), 172-181.

Fannie Gaston-Johansson, Marci Albert, Ellen Fagan, Lani Zimmerman (1990) Similarities in pain descriptions of four different ethnic-culture groups. 5(2), 94-100.

I Grigorova, O Pogrebnyak (2015) Practitioner/Practice- and Patient-Based Factors Contributing to Dental Practitioner Treatment Recommendations for Patients with Pain-Related TMDs: Findings from the National Dental PBRN. 65-71.

I Grigorova, O Teslenko, L Tikhonova, A Grigorova, E Pogrebnyak (2016) Pain relief syndrome with meloxicam in the form of orodispersible tablets // Health of Ukraine. 3-4.

Y Henrotin, T Reginster (1999) In vitro difference among nonsteroidal antiinflammatory drug in their activities related to osteoarthritis pathophysiology. 7, 355-357.

Chathuraka Jayasuriya, Q Chen (2013) Role of Inflammation in Osteoarthritis. 03(02), 121.

K Jordan, N Arden, M Doherty, B Bannwarth, J Bijlsma, P Dieppe, K Gunther, H Hauselmann, G Herrero-Beaumont, P Kaklamanis, S Lohmander, B Leeb, M Lequesne, B Mazieres, E Martin-Mola, K Pavelka, A Pendleton, L Punzi, U Serni, B Swoboda, G Verbruggen, I Zimmerman-Gorska, M Dougados (2003) EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). 62(12), 1145-1155.

Kharchenko Yu (2014) Adequate assessment of pain is the key to its successful treatment // Universum: Medicine and pharmacology: electron. (4).

S Kothari, L Baad-Hansen, L Hansen (2016) Pain profiling of patients with temporomandibular joint arthralgia and osteoarthritis diagnosed with different imaging techniques. 17(1), 61.

W Lim, J Toothman, J Miller, R Tallents, S Brouxhon, M Olschowka, S Kyrkanides (2009) IL-1β Inhibits TGFβ in the Temporomandibular Joint. 88(6), 557-562.

J Martel-Pelletier, J.-P Pelletier (2007) Inflammatory factors involved in osteoarthritis. 3-13.

S Mastbergen, J Bijlsma, F Lafeber (2005) Selective COX-2 inhibition is favorable to human early and late-stage osteoarthritic cartilage: a human in vitro study. 13(6), 519-526.

I Mazur, I Suprunovich (2016) Substantiation of the effectiveness of application of orodispersed form of meloxicam in dental practice // Modern dentistry. 10-14.

Meghan Murphy, Regina Macbarb, Mark Wong, Kyriacos Athanasiou (2013) Temporomandibular Disorders: A Review of Etiology, Clinical Management, and Tissue Engineering Strategies. 28(6), e393-e414.

G Ruzin, G Bida (2009) Postoperative anesthesia in maxillofacial surgery // Ukrainian Dental Almanac. 22-24.

D Sanchez-Matienzo, A Arana, J Castellsague, S Perez-Gutthann (2006) Hepatic disorders in patients treated with COX-2 selective inhibitors or nonselective NSAIDs: a case/noncase analysis of spontaneous reports. 28(8), 1123-1132.

G Singh, S Lanes, G Triadafilopoulos (2004) Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam. 117(2), 100-106.

G Singh, G Triadafilopoulos (2001) Meloxicam has a low risk of serious gastrointestinal complication: pooled analysis of 27039 patients: the results of the IMPROVE trial // EULAR Congress.

Ivan Tarasov, Alexander Nikitin, Nadezhda Perova, Rinat Chukumov, Daniil Gusarov (2016) CONSERVATIVE TREATMENT OF ARTHROSIS OF THE TEMPOROMANDIBULAR JOINT. 9(4), 66-71.

R.-D Treede, W Rief, A Barke (2015) A classification of chronic pain for ICD-11. 156(6), 1003-1007.

W Van Den Berg (2000) Pathophisiology of osteoarthritis. 67, 555-556.

O Volovar (2013) Phenotype signs of connective tissue dysplasia in patients with diseases of the temporomandibular joint // Ukr Med Chasopys. 188-192.

O Volovar, O Kryzhanivska (2015) SERRATIOPEPTIDASE IN THE COMPLEX TREATMENT AT PATIENTS WITH TEMPOROMANDIBULAR JOINT DISEASES. 15(4), 50-56.

O Volovar, O Kryzhanivska (2014) SERRATIOPEPTIDASE IN THE COMPLEX TREATMENT AT PATIENTS WITH TEMPOROMANDIBULAR JOINT DISEASES. (4), 50-56.

X Wang, X Kou, J Mao (2012) Sustained inflammation induces degeneration of the temporomandibular joint. 91(5), 499-505.

M Wieckiewicz, K Boening, P Wiland, Y Shiau, A Paradowska-Stolarz (2015) Reported concepts for the treatment modalities and pain management of temporomandibular disorders. 16, 106-115.

W Zhang, M Doherty, B Leeb, L Alekseeva, N Arden, J Bijlsma, F Dinçer, K Dziedzic, H Häuselmann, G Herrero-Beaumont, P Kaklamanis, S Lohmander, E Maheu, E Martín-Mola, K Pavelka, L Punzi, S Reiter, J Sautner, J Smolen, G Verbruggen, I Zimmermann-Górska (2007) EULAR evidence based recommendations for the management of hand osteoarthritis: Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). 66(3), 377-388.